Hematologic Malignancies Detection Global Market Report 2024

Description

Hematologic malignancy detection involves identifying cancers that impact the blood, bone marrow, and lymphatic system, such as leukemia, lymphoma, and multiple myeloma. These types of cancers interfere with the normal production and function of blood cells.

Key methods for detecting hematologic malignancies include polymerase chain reaction (PCR), immunochemistry, next-generation sequencing, fluorescence in situ hybridization, and other techniques. PCR is a method used to amplify small DNA samples, which facilitates the analysis and detection of genetic mutations or abnormalities linked to hematologic cancers. This technique is applicable for conditions like multiple myeloma, myelodysplastic syndrome, leukemia, myeloproliferative neoplasms, and lymphoma, and is used in various settings, including hospitals, specialty clinics, and home care.

The hematologic malignancies detection market research report is one of a series of new reports from The Business Research Company that provides hematologic malignancies detection market statistics, including hematologic malignancies detection industry global market size, regional shares, competitors with a hematologic malignancies detection market share, detailed hematologic malignancies detection market segments, market trends and opportunities, and any further data you may need to thrive in the hematologic malignancies detection industry. This hematologic malignancies detection market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hematologic malignancies detection market size has grown rapidly in recent years. It will grow from $2.33 billion in 2023 to $2.68 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%. The historical growth can be attributed to several factors, including rising incidence rates of hematologic conditions, increased awareness of their significance, growing demand from patients, supportive regulatory frameworks, and the advancement of digital health technology.

The hematologic malignancies detection market size is expected to see rapid growth in the next few years. It will grow to $4.74 billion in 2028 at a compound annual growth rate (CAGR) of 15.4%. The anticipated growth during the forecast period can be attributed to several factors, including the expansion of healthcare infrastructure, government initiatives and funding, broader health insurance coverage, and advancements in data management systems. Key trends expected during this period include improved resolution of genetic and epigenetic data, advanced methods for profiling protein expressions, enhanced immunoassay techniques, the development of nanomaterials and nanosensors, and the growth of telemedicine platforms.

The rising incidence of blood cancer is anticipated to drive the growth of the hematologic malignancy detection market. Blood cancer, which includes cancers affecting the blood, bone marrow, or lymphatic system, disrupts normal blood cell production and function. Factors contributing to the increased prevalence of blood cancer include aging populations and advancements in diagnostic techniques that enable earlier and more precise detection. Effective detection of hematologic malignancies is crucial for treatment, as it allows for early and accurate diagnosis, facilitating personalized and effective treatment strategies. For example, in March 2024, the Leukemia & Lymphoma Society, a US-based professional organization, reported that approximately 437,337 people in the US are living with or in remission from leukemia, with around 59,610 new cases expected to be diagnosed in 2024. Consequently, the growing prevalence of blood cancer is fueling the expansion of the hematologic malignancy detection market.

Leading companies in the hematologic malignancy detection market are concentrating on developing advanced solutions, such as blood cancer diagnostic tests, to improve diagnostic accuracy and patient outcomes. These tests are essential for detecting and confirming the presence of hematologic malignancies like leukemia, lymphoma, and multiple myeloma. For instance, in November 2023, Roswell Park Comprehensive Cancer Center, a US-based research and treatment facility, introduced PanHeme, a cutting-edge blood cancer diagnostic test that leverages next-generation gene sequencing technology. PanHeme identifies genetic mutations in blood cancers within 72 hours, a significant improvement over traditional methods. This rapid turnaround allows for the development of personalized treatment plans and the use of targeted FDA-approved therapies based on specific mutations.

In February 2022, Becton, Dickinson and Company, a US-based medical technology firm, acquired Cytognos S.L. for an undisclosed amount. This acquisition allows Becton, Dickinson and Company to enhance its capabilities in blood cancer diagnostics and post-treatment monitoring by leveraging Cytognos' expertise in flow cytometry and minimal residual disease detection. Cytognos S.L., based in Spain, specializes in clinical diagnostics, particularly in immune monitoring and blood cancer diagnosis solutions.

Major companies operating in the hematologic malignancies detection market are AbbVie Inc., Sanofi-Aventis U.S LLC, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Novartis AG, Becton Dickinson and Company, Laboratory Corporation of America Holdings, ICON plc, Agilent Technologies Inc., Illumina Inc., Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Kite Pharma Inc., ArcherDx Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Tempus Labs Inc., Adaptive Biotechnologies Corporation, Freenome Inc., Invivoscribe Technologies Inc., Asuragen Inc., Celldex Therapeutics Inc.

North America was the largest region in the hematologic malignancies detection market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hematologic malignancies detection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hematologic malignancies detection market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hematologic malignancy detection market consists of revenues earned by entities by providing services such as diagnostic testing, imaging studies, clinical evaluation, genetic counseling, and monitoring and follow-up. The market value includes the value of related goods sold by the service provider or included within the service offering. The hematologic malignancy detection market also includes sales of products including bone marrow aspiration and biopsy kits, flow cytometers, fluorescence in situ hybridization (FISH), and IHC staining kits. Values in this market are factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hematologic Malignancies Detection Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hematologic malignancies detection market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hematologic malignancies detection ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hematologic malignancies detection market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Polymerase Chain Reaction; Immunochemistry; Next Generation Sequencing; Fluorescence In Situ Hybridization; Other Types
2) By Application: Multiple Myeloma; Myelodysplastic Syndrome; Leukemia; Myeloproliferative Neoplasms; Lymphoma; Other Application
3) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
Companies Mentioned: AbbVie Inc.; Sanofi-Aventis U.S LLC; Bristol-Myers Squibb Company; Thermo Fisher Scientific Inc.; Abbott Laboratories Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r20659

1. Executive Summary

2. Hematologic Malignancies Detection Market Characteristics

3. Hematologic Malignancies Detection Market Trends And Strategies

4. Hematologic Malignancies Detection Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Hematologic Malignancies Detection Market Size and Growth

5.1. Global Hematologic Malignancies Detection Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Hematologic Malignancies Detection Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Hematologic Malignancies Detection Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Hematologic Malignancies Detection Market Segmentation

6.1. Global Hematologic Malignancies Detection Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Polymerase Chain Reaction
Immunochemistry
Next Generation Sequencing
Fluorescence In Situ Hybridization
Other Types
6.2. Global Hematologic Malignancies Detection Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Multiple Myeloma
Myelodysplastic Syndrome
Leukemia
Myeloproliferative Neoplasms
Lymphoma
Other Application
6.3. Global Hematologic Malignancies Detection Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Specialty Clinics
Homecare
Other End-Users

7. Hematologic Malignancies Detection Market Regional And Country Analysis

7.1. Global Hematologic Malignancies Detection Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Hematologic Malignancies Detection Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Hematologic Malignancies Detection Market

8.1. Asia-Pacific Hematologic Malignancies Detection Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Hematologic Malignancies Detection Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Hematologic Malignancies Detection Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Hematologic Malignancies Detection Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Hematologic Malignancies Detection Market

9.1. China Hematologic Malignancies Detection Market Overview
9.2. China Hematologic Malignancies Detection Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Hematologic Malignancies Detection Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Hematologic Malignancies Detection Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Hematologic Malignancies Detection Market

10.1. India Hematologic Malignancies Detection Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Hematologic Malignancies Detection Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Hematologic Malignancies Detection Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Hematologic Malignancies Detection Market

11.1. Japan Hematologic Malignancies Detection Market Overview
11.2. Japan Hematologic Malignancies Detection Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Hematologic Malignancies Detection Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Hematologic Malignancies Detection Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Hematologic Malignancies Detection Market

12.1. Australia Hematologic Malignancies Detection Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Hematologic Malignancies Detection Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Hematologic Malignancies Detection Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Hematologic Malignancies Detection Market

13.1. Indonesia Hematologic Malignancies Detection Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Hematologic Malignancies Detection Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Hematologic Malignancies Detection Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Hematologic Malignancies Detection Market

14.1. South Korea Hematologic Malignancies Detection Market Overview
14.2. South Korea Hematologic Malignancies Detection Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Hematologic Malignancies Detection Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Hematologic Malignancies Detection Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Hematologic Malignancies Detection Market

15.1. Western Europe Hematologic Malignancies Detection Market Overview
15.2. Western Europe Hematologic Malignancies Detection Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Hematologic Malignancies Detection Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Hematologic Malignancies Detection Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Hematologic Malignancies Detection Market

16.1. UK Hematologic Malignancies Detection Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Hematologic Malignancies Detection Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Hematologic Malignancies Detection Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Hematologic Malignancies Detection Market

17.1. Germany Hematologic Malignancies Detection Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Hematologic Malignancies Detection Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Hematologic Malignancies Detection Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Hematologic Malignancies Detection Market

18.1. France Hematologic Malignancies Detection Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Hematologic Malignancies Detection Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Hematologic Malignancies Detection Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Hematologic Malignancies Detection Market

19.1. Italy Hematologic Malignancies Detection Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Hematologic Malignancies Detection Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Hematologic Malignancies Detection Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Hematologic Malignancies Detection Market

20.1. Spain Hematologic Malignancies Detection Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Hematologic Malignancies Detection Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Hematologic Malignancies Detection Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Hematologic Malignancies Detection Market

21.1. Eastern Europe Hematologic Malignancies Detection Market Overview
21.2. Eastern Europe Hematologic Malignancies Detection Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Hematologic Malignancies Detection Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Hematologic Malignancies Detection Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Hematologic Malignancies Detection Market

22.1. Russia Hematologic Malignancies Detection Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Hematologic Malignancies Detection Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Hematologic Malignancies Detection Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Hematologic Malignancies Detection Market

23.1. North America Hematologic Malignancies Detection Market Overview
23.2. North America Hematologic Malignancies Detection Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Hematologic Malignancies Detection Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Hematologic Malignancies Detection Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Hematologic Malignancies Detection Market

24.1. USA Hematologic Malignancies Detection Market Overview
24.2. USA Hematologic Malignancies Detection Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Hematologic Malignancies Detection Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Hematologic Malignancies Detection Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Hematologic Malignancies Detection Market

25.1. Canada Hematologic Malignancies Detection Market Overview
25.2. Canada Hematologic Malignancies Detection Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Hematologic Malignancies Detection Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Hematologic Malignancies Detection Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Hematologic Malignancies Detection Market

26.1. South America Hematologic Malignancies Detection Market Overview
26.2. South America Hematologic Malignancies Detection Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Hematologic Malignancies Detection Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Hematologic Malignancies Detection Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Hematologic Malignancies Detection Market

27.1. Brazil Hematologic Malignancies Detection Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Hematologic Malignancies Detection Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Hematologic Malignancies Detection Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Hematologic Malignancies Detection Market

28.1. Middle East Hematologic Malignancies Detection Market Overview
28.2. Middle East Hematologic Malignancies Detection Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Hematologic Malignancies Detection Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Hematologic Malignancies Detection Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Hematologic Malignancies Detection Market

29.1. Africa Hematologic Malignancies Detection Market Overview
29.2. Africa Hematologic Malignancies Detection Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Hematologic Malignancies Detection Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Hematologic Malignancies Detection Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Hematologic Malignancies Detection Market Competitive Landscape And Company Profiles

30.1. Hematologic Malignancies Detection Market Competitive Landscape
30.2. Hematologic Malignancies Detection Market Company Profiles
- 30.2.1. AbbVie Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Sanofi-Aventis U.S LLC
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Bristol-Myers Squibb Company
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Thermo Fisher Scientific Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Abbott Laboratories Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Hematologic Malignancies Detection Market Other Major And Innovative Companies

31.1. Novartis AG
31.2. Becton Dickinson and Company
31.3. Laboratory Corporation of America Holdings
31.4. ICON plc
31.5. Agilent Technologies Inc.
31.6. Illumina Inc.
31.7. Beckman Coulter Inc.
31.8. Sysmex Corporation
31.9. Bio-Rad Laboratories Inc.
31.10. QIAGEN N.V.
31.11. Kite Pharma Inc.
31.12. ArcherDx Inc.
31.13. Invitae Corporation
31.14. NeoGenomics Laboratories Inc.
31.15. Tempus Labs Inc.

32. Global Hematologic Malignancies Detection Market Competitive Benchmarking

33. Global Hematologic Malignancies Detection Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Hematologic Malignancies Detection Market

35. Hematologic Malignancies Detection Market Future Outlook and Potential Analysis

35.1 Hematologic Malignancies Detection Market In 2028 - Countries Offering Most New Opportunities
35.2 Hematologic Malignancies Detection Market In 2028 - Segments Offering Most New Opportunities
35.3 Hematologic Malignancies Detection Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer